Home/Filings/4/0001062993-23-019440
4//SEC Filing

Wells David R. 4

Accession 0001062993-23-019440

CIK 0001840877other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:09 PM ET

Size

5.3 KB

Accession

0001062993-23-019440

Insider Transaction Report

Form 4
Period: 2023-10-15
Wells David R.
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-10-15+293,250293,250 total
    Exercise: $2.40Exp: 2033-10-15Class A Common Stock (293,250 underlying)
Footnotes (1)
  • [F1]Options to purchase 73,313 shares vest on 10/15/2024, and the remaining 219,937 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.

Issuer

Envoy Medical, Inc.

CIK 0001840877

Entity typeother

Related Parties

1
  • filerCIK 0001480371

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:09 PM ET
Size
5.3 KB